Average Co-Inventor Count = 5.50
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Hoffmann-la Roche Inc. (16 from 4,942 patents)
2. Huawei Technologies Co., Limited (1 from 27,108 patents)
3. F. Hoffmann-la Roche Ag (168 patents)
17 patents:
1. 11771699 - Combined treatment with a TLR7 agonist and an HBV capsid assembly inhibitor
2. RE49481 - Compounds for the treatment and prophylaxis of respiratory syncytial virus disease
3. 11337982 - Combined treatment with a TLR7 agonist and an HBV capsid assembly inhibitor
4. 11301029 - Method, apparatus, and system for allocating power to graphics processing unit
5. 11180525 - Process for making 3-substituted 5-amino-6H-thiazolo[4,5-d]pyrimidine-2, 7-dione compounds useful for the treatment of virus infection
6. 10752630 - 7-substituted sulfonimidoylpurinone compounds for the treatment of virus infection
7. 10618929 - 3-substituted 5-amino-6H-thiazolo[4,5-D]pyrimidine-2, 7-dione compounds for the treatment and prophylaxis of virus infection
8. 10611748 - Xanthone derivatives for the treatment of hepatitis B virus disease
9. 10596173 - Combination therapy of an HBV capsid assembly inhibitor and an interferon
10. 10233184 - 7-substituted sulfonimidoylpurinone compounds and derivatives for the treatment and prophylaxis of virus infection
11. 10189838 - Aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection
12. 10040815 - 3-substituted 5-amino-6H-thiazolo[4,5-d]pyrimidine-2,7-dione compounds for the treatment and prophylaxis of virus infection
13. 9790213 - Imidazoles for the treatment and prophylaxis of respiratory syncytial virus infection
14. 9670211 - Aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection
15. 9441008 - 3-substituted 5-amino-6H-thiazolo[4,5-D]pyrimidine-2,7-dione compounds for the treatment and prophylaxis of virus infection